Table 1. Basic characteristics of patients in the FAR NHL registry.
| Parameter | Total (N = 1,088) |
|---|---|
| Sex–male | 880 (80.9%) |
| Age | 64 ± 12; 65 (40; 82) |
| BMI | 29 ± 5; 28 (22; 39) |
| Aetiology | |
| IHD | 545 (50.1%) |
| IHD+DCM | 7 (0.6%) |
| DCM | 453 (41.6%) |
| HCM | 5 (0.5%) |
| Other | 78 (7.2%) |
| SBP (mmHg) | 129 ± 17; 128 (101; 160) |
| DBP (mmHg) | 80 ± 10; 80 (61; 99) |
| Heart rate (min-1) | 74 ± 13; 72 (55; 96) |
| LVEF (%) | 31 ± 9; 30 (17; 45) |
| Atrial fibrillation | 379 (34.8%) |
| Diabetes mellitus | 422 (38.8%) |
| NYHA classification | |
| 1 | 143 (13.1%) |
| 2 | 657 (60.4%) |
| 3–4 | 288 (26.5%) |
| Haemoglobin (g/l) | 142 ± 16; 143 (113; 165) |
| Creatinine (μmol/l) | 106 ± 54; 95 (65; 172) |
| NT-proBNP (ng/L) | 1,375 ± 2,773; 511 (27; 4,886) |
| ACEI/ARB | 961 (88.3%) |
| Beta-blockers | 1020 (93.8%) |
| MRA (Verospiron) | 715 (65.7%) |
| 2-year mortality | 132 (12.1%) |
| HTX within 2 years | 24 (2.2%) |
| LVAD within 2 years | 12 (1.1%) |
| 2-year combined endpoint | 162 (14.9%) |
Continuous variables are described by mean ± SD and median (5th percentile; 95th percentile); categorical variables are characterised by absolute and relative frequencies.
BMI, body mass index; DBP, diastolic blood pressure; DCM, dilated cardiomyopathy; HCM, hypertrophic cardiomyopathy; IHD, ischaemic heart disease; LVEF, left ventricular ejection fraction; SBP, systolic blood pressure.